HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation

Journal of Medical Virology

Volumn 80, Issue 9, 2008, Pages 1507-1514

  Gibellini, Davide ^a   De Crignis, Elisa ^a   Ponti, Cristina ^b   Cimatti, Laura ^a   Borderi, Marco ^a   Tschon, Matilde ^c   Giardino, Roberto ^c   Re, Maria Carla ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^d NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Apoptosis; HIV 1; Osteoblasts; TNF

Indexed keywords

POLYCLONAL ANTIBODY; RECOMBINANT GLYCOPROTEIN GP 120; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS RNA;

APOPTOSIS; ARTICLE; BONE INJURY; CELL CULTURE; CELL INTERACTION; CELL MEMBRANE; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; OSTEOBLAST; OSTEOCLAST; PROTEIN INTERACTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; UPREGULATION; VIRUS STRAIN;

APOPTOSIS; CELL LINE; CELLS, CULTURED; DNA, VIRAL; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; OSTEOBLASTS; PROVIRUSES; RNA, VIRAL; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 48249097085     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21266     Document Type: Article

References (54)

1. Abbas S, Zhang YH, Clohisy JC, Abu-Amer Y. 2003. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 22:33-41.
2. Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, Teitelbaum SL. 2000. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 275:27307-27310.
3. Adachi A, Koenig S, Gendelman HE, Daugherty D, Gattoni-Celli S, Fauci AS, Martin MA. 1987. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol 61:209-213.
4. Aiuti A, Turchetto L, Cota M, Cipponi A, Brambilla A, Arcelloni C, Paroni R, Vicenzi E, Bordignon C, Poli G. 1999. Human CD34+ cells express CXCR4 and its ligand stromal cell - Derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood 94:62-73.
5. Amorosa V, Tebas P. 2000. Bone disease and HIV infection. Clin Infect Dis 42:108-114.
6. Badley AD, Dockrell D, Simpson M, Schut R, Lynch DH, Leibson P, Paya CV. 1997. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 185:55-64.
7. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099-1106.
8. Bergenstock MK, Partridge NC. 2007. Parathyroid hormone stimulation of noncanonical Wnt signaling in bone. Ann NY Acad Sci 116:354-359.
9. Blair HC, Robinson LJ, Zaidi M. 2005. Osteoclast signalling pathways. Biochem Biophys Res Commun 328:728-738.
10. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
11. Brown TT, Qaqish RB. 2006. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS 20:2165-2174.
12. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. 2003. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17:1917-1923.
13. Bu R, Borysenko CW, Li Y, Cao L, Sabokbar A, Blair HC. 2003. Expression and function of TNF-family proteins and receptors in human ostoblasts. Bone 33:760-770.
14. Campbell DG, Stephenson AJ, Li P, Oakeshott RD. 1996. Human immunodeficiency virus infection of human bone derived cells. Clin Orthop Relat Res 331:291-299.
15. Chelucci C, Federico M, Guerriero R, Mattia G, Casella I, Pelosi E, Testa U, Mariani G, Hassan HJ, Peschle C. 1998. Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 91:1225-1234.
16. Christakos S, Dhawan P, Benn B, Porta A, Hediger M, Oh GT, Jeung EB, Zhong Y, Ajibade D, Dhawan K, Joshi S. 2007. Vitamin D: Molecular mechanism of action. Ann N Y Acad Sci 116:340-348.
17. Christopherson C, Sninsky J, Kwok S. 1997. The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies. Nucleic Acids Res 25:654-658.
18. Cotter EJ, Malizia AP, Chew N, Powderly WG, Doran PP. 2007. HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses 23:1521-1530.
19. Dolan SE, Huang JS, Killilea KM, Sullivan MP, Aliabadi N, Grinspoon S. 2004. Reduced bone density in HIV-infected women. AIDS 18:475-483.
20. Fakruddin JM, Laurence J. 2003. HIV envelope gp120-mediated regulation of osteoclastogensis via receptor activator of nuclear factor kb ligand (RANKL) decretion and its modulation by certain HIV protease inhibitors through interferon-γ/RANKL cross-talk. J Biol Chem 278:48251-48258.
21. Fakruddin JM, Laurence J. 2004. Interactions among HIV-1, interferon Gamma and receptor of activated NF-κB ligand (RANKL): Implications for HIV pathogenesis. Clin Exp Immunol 137:538-545.
22. Fakruddin JM, Laurence J. 2005. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch Virol 150:67-78.
23. Fauci AS. 2003. HIV and AIDS: 20 years of science. Nat Med 9:839-843.
24. Fausto A, Bongiovanni P, Cicconi P, Menicagli L, Ligabo EV, Melzi S, Bini T, Sardanelli F, Cornalba G, Monforte A. 2006. Potential predictive factors of osteoporosis in HIV-positive patients. Bone 38:893-897.
25. Feng X. 2005. Regulatory roles and molecular signalling of TNF family members in osteoclats. Gene 350:1-13.
26. Finkel TH, Banda NK. 1994. Indirect mechanisms of HIV pathogenesis: How does HIV kill T cells? Curr Opin Immunol 6:605-615.
27. Gibellini D, Re MC, Vitone F, Rizzo N, Maldini C, La Placa M, Zauli G. 2003. Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein. Clin Exp Immunol 131:428-435.
28. Gibellini D, Vitone F, Gori E, La Placa M, Re MC. 2004. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. J Virol Meth 115:183-189.
29. Gibellini D, Re MC, Ponti C, Vitone F, Bon I, Fabbri G, Di Iasio MG, Zauli G. 2005. HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity. J Cell Physiol 203:546-556.
30. Gibellini D, Vitone F, Buzzi M, Schiavone P, De Crignis E, Cicola R, Conte R, Ponti C, Re MC. 2007a. HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction. J Cell Physiol 210:315-324.
31. Gibellini D, Borderi M, De Crignis E, Cicola R, Vescini F, Caudarella R, Chiodo F, Re MC. 2007b. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. J Med Virol 79:1446-1454.
32. Guillemard E, Jacquemot C, Aillet F, Schmitt N, Barré-Sinoussi F, Israël N. 2004. Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF. Virology 329:371-380.
33. Herbein G, Van Lint C, Lovett JL, Verdin E. 1998. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J Virol 72:660-670.
34. Hill PA, Tumber A, Meikle MC. 1997. Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 138:3849-3858.
35. Klein SA, Dobmeyer JM, Dobmeyer TS, Falke D, Kabelitz D, Friese K, Helm EB, Hoelzer D, Rossol-Voth R. 1996. TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals. Eur J Med Res 1:249-258.
36. Kobayashi T, Kronenberg H. 2005. Minireview: Transcriptional regulation in development of bone. Endocrinology 146:1012-1017.
37. Kostenuik PJ. 2005. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5:618-625.
38. Landonio S, Quirino T, Bonfanti P, Gabris A, Boccassini L, Gulisano C, Vulpio L, Ricci E, Carrabba M, Vigevani GM. 2004. Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART. Biomed Pharmacother 58:505-508.
39. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97:1566-1571.
40. Lisignoli G, Toneguzzi S, Piacentini A, Cristino S, Grassi F, Cavallo C, Facchini A. 2006. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 206:78-85.
41. Mattson MP, Haughey NJ, Nath A. 2005. Cell death in HIV dementia. Cell Death Differ 12:893-904.
42. Mellert W, Kleinschmidt A, Schmidt J, Festl H, Emler S, Roth WK, Erfle V. 1990. Infection of human fibroblast and osteoblast-like cells with HIV-1. AIDS 4:524-527.
43. Mondy K, Tebas P. 2003. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 36:S101-S105.
44. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, De Marco D, Hoffman M, Tebas P. 2003. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482-490.
45. Moses A, Nelson J, Bagby G. 1998. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91:1479-1495.
46. Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K, Yamamura M, Makino H. 2007. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Comm 356:1004-1010.
47. Nacher M, Serrano S, Gonzalez A, Hernandez A, Marinoso ML, Vilella R, Hinarejos P, Diez A, Aubia J. 2001. Osteoblasts in HIV-infected patients: HIV-1 infection and cell function. AIDS 15:2239-2243.
48. Nottet H, Janse I, De Graaf L, Bakker LJ, Visser MR, Verhoef J. 1993. Infection of epithelial cell line HEp-2 with human immunodeficiency virus type 1 is CD4 dependent. J Med Virol 40:39-43.
49. Pan G, Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. 2004. AZT enhances osteoclastogenesis and bone loss. AIDS Res Hum Retroviruses 17:513-520.
50. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R. 2001. Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98:13960-13965.
51. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE. 2000. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:63-67.
52. Yano S, Mentaverri R, Kanuparthi D, Bandyopadhyay S, Rivera A, Brown EM, Chattopadhyay N. 2005. Functional expression of beta-chemokine receptors in osteoblasts: Role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology 146:2324-2335.
53. Zauli G, Furlini G, Vitale M, Re MC, Gibellini D, Zamai L, Visani G, Borgatti P, Capitani S, La Placa M. 1994. A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. Blood 84:1896-1905.
54. Zauli G, Vitale M, Gibellini D, Capitani S. 1996. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus type 1 or gp120 mediated by endogenous Transforming Growth Factor β1. J Exp Med 183:99-108.